8.02

2.30% 0.18

After Hours: 7.98 -0.04 -0.50%

Kura Oncology Inc (KURA)

Overview News Price History Option Chain Financials Discussions Forecast

Kura Oncology Inc stock is traded at $8.02, with a volume of 1.22M. It is up +2.30% in the last 24 hours and down -12.54% over the past month. Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

Previous Close:

$7.84

Open:

$7.9

24h Volume:

1.22M

Relative Volume:

0.77

Market Cap:

$697.88M

Revenue:

Net Income/Loss:

$-168.09M

P/E Ratio:

-3.6959

EPS:

-2.17

Net Cash Flow:

$-138.01M

1W Performance:

+8.38%

1M Performance:

-12.54%

6M Performance:

+29.35%

1Y Performance:

-3.95%

1-Day Range:

$7.625

$8.045

1-Week Range:

$7.50

$8.08

52-Week Range:

$5.41

$12.49

Kura Oncology Inc Stock (KURA) Company Profile

Name

Kura Oncology Inc

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

(858) 500-8800

Address

4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA

Employee

192

Twitter

@kuraoncology

Next Earnings Date

2025-02-21

Latest SEC Filings

KURA's Discussions on Twitter

Compare KURA vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KURA Kura Oncology Inc	8.02	682.22M	0	-168.09M	-138.01M	-2.17
VRTX Vertex Pharmaceuticals Inc	465.02	117.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	783.65	82.35B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	833.54	51.64B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	308.48	42.58B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	346.42	38.87B	4.98B	69.60M	525.67M	0.5198

Kura Oncology Inc Stock (KURA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-04-25	Initiated	Guggenheim	Neutral
Feb-06-25	Downgrade	BTIG Research	Buy → Neutral
Oct-24-24	Initiated	UBS	Buy
Oct-14-24	Downgrade	Stifel	Buy → Hold
Dec-22-23	Initiated	Mizuho	Buy
Aug-11-23	Initiated	BofA Securities	Buy
Jul-27-23	Initiated	Scotiabank	Sector Perform
May-17-23	Initiated	BTIG Research	Buy
Jan-31-23	Initiated	Stifel	Buy
Jul-12-22	Initiated	Cantor Fitzgerald	Overweight
Feb-15-22	Initiated	Jefferies	Buy
May-05-21	Resumed	Credit Suisse	Outperform
Apr-26-21	Resumed	Credit Suisse	Outperform
Dec-07-20	Reiterated	H.C. Wainwright	Buy
Dec-03-20	Initiated	Stifel	Buy
Nov-05-20	Downgrade	Piper Sandler	Overweight → Neutral
Jul-07-20	Initiated	Credit Suisse	Outperform
May-05-20	Initiated	Barclays	Overweight
Jul-18-19	Initiated	Deutsche Bank	Buy
Nov-09-18	Initiated	Piper Jaffray	Overweight
Aug-01-18	Initiated	H.C. Wainwright	Buy
Oct-13-16	Resumed	Leerink Partners	Outperform
Jan-22-16	Initiated	JMP Securities	Mkt Outperform
Dec-30-15	Initiated	Oppenheimer	Outperform
Dec-16-15	Initiated	Citigroup	Buy

View All

Kura Oncology Inc Stock (KURA) Latest News

04:19 AM

IPO Launch: Is Kura Oncology Inc a strong candidate for buy and holdJuly 2025 Retail & Free Verified High Yield Trade Plans - baoquankhu1.vn

04:19 AM

Feb 11, 2026

Is Kura Oncology Inc. vulnerable to short sellersPortfolio Return Report & Daily Price Action Insights - mfd.ru

Feb 11, 2026

Feb 09, 2026

The Truth About Kura Oncology Inc: Is This Sleeper Cancer Stock About To Explode? - AD HOC NEWS

Feb 09, 2026

Feb 06, 2026

Kura Oncology (KURA) Issues Stock Options to New Employees - GuruFocus

Feb 06, 2026

Kura Oncology Grants Inducement Stock Options to New Employees as Part of 2023 Inducement Option Plan - Quiver Quantitative

Feb 06, 2026

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Feb 06, 2026

Need To Know: The Consensus Just Cut Its Kura Oncology, Inc. (NASDAQ:KURA) Estimates For 2026 - simplywall.st

Feb 06, 2026

Why (KURA) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Feb 06, 2026

Feb 04, 2026

Analyst flags Kura Oncology, Inc. (KURA) for 2026 milestones and pipeline expansion - MSN

Feb 04, 2026

Feb 02, 2026

Analyst Flags Kura Oncology, Inc. (KURA) for 2026 Milestones and Pipeline Expansion - Yahoo Finance

Feb 02, 2026

Citizens reiterates Market Outperform rating on Kura Oncology stock By Investing.com - Investing.com Canada

Feb 02, 2026

Feb 01, 2026

ETF Watch: Is AVDL vulnerable to short sellers2025 Top Decliners & High Accuracy Investment Entry Signals - baoquankhu1.vn

Feb 01, 2026

Treasury Yields: Whats the profit margin of Kura Oncology IncWeekly Trend Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn

Feb 01, 2026

Jan 31, 2026

Nan Fung Trinity HK Ltd. Invests $2.04 Million in Kura Oncology, Inc. $KURA - MarketBeat

Jan 31, 2026

Jan 30, 2026